Substance Use Disorders Clinical Trial
— RMC-PCOfficial title:
Recovery Management Checkups for Primary Care (RMC-PC) Experiment
Verified date | March 2022 |
Source | Chestnut Health Systems |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
National data show that only 8% of people with past-year substance use disorders (SUD) received any treatment for these disorders in the past year, resulting in high costs, both in terms of their own health and functioning and costs to society. Pilot work demonstrates that the proposed intervention has the potential to significantly increase SUD treatment engagement among patients with SUD within Federally Qualified Health Centers (FQHCs), and thereby reduce substance use and other related consequences. This project is being done in close collaboration with several FQHC providers to facilitate the potential for subsequent dissemination to other FQHCs and primary care settings.
Status | Completed |
Enrollment | 266 |
Est. completion date | February 28, 2022 |
Est. primary completion date | May 31, 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - scoring in the moderate to high range on the AUDIT or DAST Exclusion Criteria: - under 18 - a non-resident of Chicago or plan to move outside of Chicago within 12 months - sentenced to a confined environment most of the next 12 months - mandated to treatment because of a driving under the influence offense - not fluent in English or Spanish - cognitively unable to provide informed consent |
Country | Name | City | State |
---|---|---|---|
United States | Friend Family Health Center | Chicago | Illinois |
United States | Heartland Alliance Health | Chicago | Illinois |
United States | Christian Community Health Center | Lansing | Illinois |
United States | PCC Wellness | Oak Park | Illinois |
Lead Sponsor | Collaborator |
---|---|
Chestnut Health Systems | National Institute on Alcohol Abuse and Alcoholism (NIAAA) |
United States,
Scott CK, Grella CE, Dennis ML, Nicholson L. Linking Individuals with Substance Use Disorders (SUDs) in Primary Care to SUD Treatment: the Recovery Management Checkups-Primary Care (RMC-PC) Pilot Study. J Behav Health Serv Res. 2018 Apr;45(2):160-173. doi: 10.1007/s11414-017-9576-5. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Days from enrollment to first alcohol or other drug (AOD) treatment in the 12 months after enrollment | Days from enrollment to first alcohol or other drug (AOD) treatment in the 12 months after enrollment, measured with the Global Appraisal of Individual Needs Quick version 3 (GAIN-Q3) | 12 months post enrollment | |
Primary | Any alcohol or other drug (AOD) treatment in the 12 months after enrollment | Any alcohol or other drug (AOD) treatment in the 12 months after enrollment, dichotomized from days of treatment measured with the Global Appraisal of Individual Needs Quick version 3 (GAIN-Q3) | 12 months post treatment | |
Primary | Days of alcohol or other drug (AOD) treatment in the 12 months after enrollment | Days of alcohol or other drug (AOD) treatment in the 12 months after enrollment, measured with the Global Appraisal of Individual Needs Quick version 3 (GAIN-Q3) | 12 months post enrollment | |
Secondary | Days of alcohol use | Days of any alcohol use each quarter and over the 12 months after study enrollment | 12 months post study enrollment | |
Secondary | Days of heavy alcohol use | Days of any alcohol use each quarter and over the 12 months after study enrollment | 12 months post study enrollment | |
Secondary | Days of other drug use | Days of any drug use each quarter and over the 12 month after study enrollment | 12 months post study enrollment | |
Secondary | AOD related problems | a count of past quarter and past year symptoms of substance use disorders | 12 months post study enrollment | |
Secondary | Health Care Utilization Costs | The number of units of 11 types of health care utilization (e.g., health, mental or substance related emergency room visits, nights in a hospital/residential program, outpatient, and outpatient surgery) times their unit costs as estimated by economists. | 12 months post study enrollment |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05660434 -
Using Aromatherapy in Substance Use Disorder
|
N/A | |
Recruiting |
NCT05338268 -
Substance Use and Loneliness
|
N/A | |
Completed |
NCT04098614 -
Barriers to Substance Use Disorder Recovery
|
N/A | |
Completed |
NCT03954184 -
E-health Implementation (Iowa)
|
N/A | |
Completed |
NCT03590106 -
Cardiac Surgery Peer Recovery Support Program
|
N/A | |
Recruiting |
NCT05118204 -
Randomized Trial of Buprenorphine Microdose Inductions During Hospitalization
|
Phase 4 | |
Recruiting |
NCT06273228 -
Parenting Young Children in Pediatrics
|
N/A | |
Recruiting |
NCT05327504 -
Written Exposure Therapy for Veterans With SUD and PTSD
|
N/A | |
Terminated |
NCT03517111 -
The Impact of a Parenting Intervention on Latino Youth Health Behaviors
|
N/A | |
Completed |
NCT04284813 -
Families With Substance Use and Psychosis: A Pilot Study
|
N/A | |
Completed |
NCT04401215 -
Technologically-Augmented Referrals to Mitigate Addiction Consequences
|
N/A | |
Not yet recruiting |
NCT06187701 -
Co-Active Therapeutic Theatre (Co-ATT) for Dual-Diagnosis Patients
|
N/A | |
Not yet recruiting |
NCT06163651 -
Evaluating a One-Year Version of the Parent-Child Assistance Program
|
N/A | |
Recruiting |
NCT04296604 -
Transcranial Direct Current Stimulation (tDCS) Neuromodulation of Executive Function Across Neuropsychiatric Populations
|
N/A | |
Active, not recruiting |
NCT02382042 -
Intensive Referral Intervention to Improve Substance Use Disorder Treatment Outcomes Among Rural and Highly Rural Veterans
|
N/A | |
Terminated |
NCT01356667 -
Drum-Assisted Therapy for Native Americans
|
N/A | |
Completed |
NCT01237366 -
Study Targeting Affect Regulation
|
Phase 1/Phase 2 | |
Completed |
NCT00708890 -
Twelve Step Based Self-help Groups for Substance Related Disorders
|
N/A | |
Active, not recruiting |
NCT04048850 -
Zepatier in Patients With Substance Use
|
||
Recruiting |
NCT05976646 -
Phase Ib/2a Drug-drug Interaction Study of a Combination of 45mg Dextromethorphan With 105 mg Bupropion
|
Phase 1/Phase 2 |